https://www.selleckchem.com/pr....oducts/sacituzumab-g
For an increment of every 5kg/m in BMI, the risk for death reduced by approximately 15.6% (HR = 0.844, 95% CI 0.752-0.945, P = 0.003). Moreover, patients with higher BMI had a remarkably better ORR (OR = 0.468, 95% CI 0.263-0.833, P = 0.010; I = 73.6%) than that of those with lower BMI. However, no statistically significant differences were found in the incidence of any grade irAEs (P = 0.073) and ≥ 3 grade irAEs (P = 0.105) between higher and lower BMI. Higher BMI is significantly associated with improved outcomes in pat
Gefällt mir
Kommentar
Teilen
